What is the main purpose of this 8-K filing?

This filing reports on Cardinal Health's completion of a public offering of $2.85 billion in senior notes. The primary purpose of raising these funds is to finance a portion of the consideration for its proposed acquisitions of The GI Alliance Holdings, LLC and Advanced Diabetes Supply Group.

What are the terms of the newly issued notes?

The company issued four series of notes: $500 million of 4.700% Notes due 2026, $750 million of 5.000% Notes due 2029, $1 billion of 5.350% Notes due 2034, and $650 million of 5.750% Notes due 2054. These notes are governed by an Indenture as supplemented by a Second Supplemental Indenture.

What happens if the GIA Acquisition does not close?

If The GI Alliance Acquisition is not consummated by November 11, 2025 (or a later agreed-upon date), or if Cardinal Health decides not to proceed with it, the company is obligated to redeem all of the issued notes. This 'Special Mandatory Redemption' would occur at 101% of the aggregate principal amount of the notes, plus accrued and unpaid interest.

How does this debt issuance impact Cardinal Health's existing financing plans?

The proceeds from this note offering have reduced the need for a previously committed $2.9 billion bridge loan facility. Cardinal Health has notified the lender that excess commitments under that facility have been terminated, indicating that this debt offering is the primary source of funding for the acquisitions at this time.

CAH 8-K: Material Agreements & Financial Events

Summary

Cardinal Health, Inc. (CAH) has filed an 8-K report detailing a significant debt financing event. The company successfully completed a public offering, raising a total of $2.85 billion through the issuance of four tranches of senior notes with varying maturity dates and interest rates. These notes include $500 million in 4.700% Notes due 2026, $750 million in 5.000% Notes due 2029, $1 billion in 5.350% Notes due 2034, and $650 million in 5.750% Notes due 2054. The primary purpose of this debt issuance is to fund a portion of the consideration for two anticipated acquisitions: The GI Alliance Holdings, LLC (GIA Acquisition) and Advanced Diabetes Supply Group. This strategic move signals Cardinal Health's intent to expand its operations through targeted acquisitions. The company also disclosed that if the GIA Acquisition is not consummated by a specified date, or if the company decides not to proceed, it will be required to redeem these notes at a premium (101% of principal plus accrued interest), indicating a contingency plan tied to the success of the GIA Acquisition.

Key Highlights

1Cardinal Health raised $2.85 billion in aggregate principal amount through a public offering of senior notes.
2The notes consist of four series with maturities in 2026, 2029, 2034, and 2054, carrying interest rates from 4.700% to 5.750%.
3The proceeds are earmarked to partially finance the proposed acquisitions of The GI Alliance Holdings, LLC and Advanced Diabetes Supply Group.
4This debt issuance is part of Cardinal Health's strategy to fund significant growth through acquisitions.
5A 'Special Mandatory Redemption' clause is in effect, requiring the company to redeem the notes at a premium if the GIA Acquisition is not completed by a specified date or is abandoned.
6The company terminated excess commitments under a previously established bridge loan facility, as the note offering reduced the need for that financing.
7The financing was conducted under an effective registration statement on Form S-3 previously filed with the SEC.

CARDINAL HEALTH INC 8-K Report, Material Agreement (Nov 22, 2024)

Summary

Key Highlights

Frequently Asked Questions